319 related articles for article (PubMed ID: 21389098)
1. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
2. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
[TBL] [Abstract][Full Text] [Related]
3. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
5. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
[TBL] [Abstract][Full Text] [Related]
6. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
[TBL] [Abstract][Full Text] [Related]
7. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
[TBL] [Abstract][Full Text] [Related]
8. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
[TBL] [Abstract][Full Text] [Related]
9. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
[TBL] [Abstract][Full Text] [Related]
10. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
12. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
[TBL] [Abstract][Full Text] [Related]
13. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
14. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
15. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation testing with S5 for triage of high-risk HPV positive women.
Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
[TBL] [Abstract][Full Text] [Related]
17. Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in Kenya.
De Vuyst H; Franceschi S; Plummer M; Mugo NR; Sakr SR; Meijer CJ; Heideman DA; Tenet V; Snijders PJ; Hesselink AT; Chung MH
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):311-8. PubMed ID: 26473640
[TBL] [Abstract][Full Text] [Related]
18. Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.
Uijterwaal MH; van Zummeren M; Kocken M; Luttmer R; Berkhof J; Witte BI; van Baal WM; Graziosi GCM; Verheijen RHM; Helmerhorst TJM; van Dijken DKE; Spruijt JWM; van Kemenade FJ; Fransen-Daalmeijer N; Bekker-Lettink M; Heideman DAM; Snijders PJF; Steenbergen RDM; Meijer CJLM
Gynecol Oncol; 2016 Oct; 143(1):135-142. PubMed ID: 27430395
[TBL] [Abstract][Full Text] [Related]
19. Performance of
Molano M; Machalek DA; Tan G; Garland S; Balgovind P; Haqshenas G; Munnull G; Phillips S; Badman SG; Bolnga J; Cornall AM; Gabuzzi J; Kombati Z; Brotherton J; Saville M; Hawkes D; Kaldor J; Toliman PJ; Vallely AJ; Murray GL
BMJ Open; 2024 Jun; 14(6):e081282. PubMed ID: 38904134
[TBL] [Abstract][Full Text] [Related]
20. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer.
De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ
J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
